Last edition
News about Market
LB Pharmaceuticals Seeks 322 Million USD Valuation in Rare Biotech IPO Amid Market Slowdown
LB Pharmaceuticals, a cash-strapped drug developer, is targeting a valuation of up to 322 million USD (approximately 295 million EURO) in its upcoming New York initial public offering, which could become the first significant biotech listing in several months.
Market | 09/09/2025 | By Darshana | 284
Johnson & Johnson has launched two new products for astigmatic patients in Europe and the Middle East, including the first daily disposable multifocal contact lens for astigmatic presbyopes.
Market | 04/09/2025 | By Dineshwori | 613
Asia-Pacific Emerges as Fastest-Growing Market for Surgical Robotics
The Asia Pacific region is gaining momentum in the global surgical robotics market, with countries like China, India, Japan, and South Korea driving forward the regional surge in demand and deployment.
Market | 03/09/2025 | By Dineshwori | 345
Evernorth Invests USD 3.5 Billion in Shields to Deepen Specialty Pharmacy Reach
Evernorth, a subsidiary of Cigna Group, is investing USD 3.5 billion in Shields Health Solutions, a company focused on specialty pharmacy management. This investment arrives as Shields establishes itself as a standalone entity following its acquisition by private equity firm Sycamore Partners after the Walgreens demerger.
Market | 03/09/2025 | By Darshana | 224
CapVest Acquires Majority Stake in Stada, Abandoning IPO Plans
CapVest Partners, a London-based private equity firm, has agreed to acquire a majority stake in German pharmaceutical company Stada Arzneimittel, effectively halting the drugmaker’s previously explored initial public offering (IPO).
Market | 02/09/2025 | By Darshana | 294
Biopharma Firms See 5.7 Percent Market Cap Drop in Q2 2025: Globaldata
Twenty biopharmaceutical companies have reported a 5.7 percent quarter-on-quarter (QoQ) downturn in their combined market capitalisation from USD 3.9 trillion on 31 March, 2025 to USD 3.7 trillion on 30 June, 2025.
Market | 01/09/2025 | By Dineshwori | 222
Stada Eyes Autumn IPO as Sale Talks Stall and Market Conditions Improve
Stada and its owners are also considering alternative ownership options, including a potential sale. The company previously held talks with private equity firm CapVest, which would have valued Stada at around 10 billion euro including debt. Those discussions have since stalled, prompting a stronger push toward the IPO route.
Market | 29/08/2025 | By Darshana | 117
While North America is projected to remain the largest market for pharmaceutical stability and storage services, the Asia-Pacific (APAC) region is expected to record the fastest CAGR during the forecast period.
Market | 29/08/2025 | By Dineshwori | 153
Santhera Partners with Ikris Pharma Network for Distribution of AGAMREE in India
Swiss specialty pharma company Santhera Pharmaceuticals has entered into an exclusive agreement with Ikris Pharma Network to distribute AGAMREE (vamorolone) in India for the treatment of Duchenne muscular dystrophy (DMD) in patients aged four years and above.
Market | 29/08/2025 | By Dineshwori | 408
Esaote North America and Epica International Partner to Expand MRI and CT Imaging Market Reach
Esaote North America has entered into a strategic partnership with Epica International to expand market presence and accelerate the adoption of high-performance MRI and CT solutions across the human and veterinary healthcare sectors.
Market | 28/08/2025 | By Dineshwori | 127
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy